Featured Research

from universities, journals, and other organizations

Imaging Damaged Brain Cells In Living Mice Provides Alzheimer's Clues

Date:
November 17, 2003
Source:
Washington University School Of Medicine
Summary:
Using recently developed techniques for imaging individual cells in living animals, a team led by researchers at Washington University School of Medicine in St. Louis has watched as Alzheimer's-like brain plaques damage mouse brain cells.

New Orleans, Nov. 12, 2003 -- Using recently developed techniques for imaging individual cells in living animals, a team led by researchers at Washington University School of Medicine in St. Louis has watched as Alzheimer's-like brain plaques damage mouse brain cells.

The results will be presented at 9 a.m. CT on Wednesday, Nov. 12, at the 33rd Annual Meeting of the Society for Neuroscience in New Orleans.

"This work is very exciting," says principal investigator David M. Holtzman, M.D. "We've been able to visualize damaged nerve connections in living animals and follow them over time in the same animal. Our next step is to determine whether such damage is reversible."

Holtzman is the Andrew B. and Gretchen P. Jones Professor of Neurology and head of the Department of Neurology, the Charlotte and Paul Hagemann Professor of Neurology and a professor of molecular biology and pharmacology. The first author is Robert P. Brendza, Ph.D., research instructor in neurology.

The study was conducted in collaboration with Brian Bacskai, Ph.D., investigator at Massachusetts General Institute for Neurodegenerative Disorders and an assistant professor of neurology at Harvard Medical School; and Bradley Hyman, M.D., Ph.D., director of the Alzheimer's Unit at the Massachusetts General Institute for Neurodegenerative Disorders; and John B. Penney Jr. Professor of Neurology at Harvard Medical School; William E. Klunk, M.D., Ph.D., director of psychiatry of the Alzheimer's Disease Research Center at the University of Pittsburgh; and Kelly Bales, senior biologist, and Steven Paul, M.D., executive vice president for science and technology at Eli Lilly and Co.

In the 1990s, biologists discovered the protein that makes certain jellyfish luminescent also could be used to generate fluorescent cells in other species. By shining light on a living mouse engineered to contain these proteins, researchers can watch cellular activity over time using a multiphoton microscope, a sophisticated new microscope technique.

Holtzman's team used this technique to examine the brains of mice that develop plaques similar to those characteristic of Alzheimer's disease. The mice also were engineered to have a subset of brain cells, or neurons, that express yellow fluorescent protein. Using this model, they observed neurons becoming increasingly disrupted by brain plaques over time.

"We plan to use this system to further examine the process of nerve cell damage and degeneration," Holtzman says. "This line of research should provide new insight into the underlying processes involved in the development of Alzheimer's disease and help us determine whether the proteins that accumulate as brain plaques are a useful and feasible target for Alzheimer's therapies."

###

Brendza RP, Bacskai BJ, Simmons KA, Skoch JM, Klunk WE, Mathis CA, Bales KR, Paul SM, Hyman BT, Holtzman DH. Imaging dystrophy in vivo in fluorescent PDAPP transgenic mice. Society for Neuroscience 33rd Annual Meeting. Nov. 12, 2003.

Funding from the National Institutes of Health, the Alzheimer's Association and Eli Lilly and Company supported this research.

The full-time and volunteer faculty of Washington University School of Medicine are the physicians and surgeons of Barnes-Jewish and St. Louis Children's hospitals. The School of Medicine is one of the leading medical research, teaching and patient-care institutions in the nation. Through its affiliations with Barnes-Jewish and St. Louis Children's hospitals, the School of Medicine is linked to BJC HealthCare.


Story Source:

The above story is based on materials provided by Washington University School Of Medicine. Note: Materials may be edited for content and length.


Cite This Page:

Washington University School Of Medicine. "Imaging Damaged Brain Cells In Living Mice Provides Alzheimer's Clues." ScienceDaily. ScienceDaily, 17 November 2003. <www.sciencedaily.com/releases/2003/11/031113064952.htm>.
Washington University School Of Medicine. (2003, November 17). Imaging Damaged Brain Cells In Living Mice Provides Alzheimer's Clues. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2003/11/031113064952.htm
Washington University School Of Medicine. "Imaging Damaged Brain Cells In Living Mice Provides Alzheimer's Clues." ScienceDaily. www.sciencedaily.com/releases/2003/11/031113064952.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins